168 related articles for article (PubMed ID: 1733855)
1. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
[TBL] [Abstract][Full Text] [Related]
5. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
[TBL] [Abstract][Full Text] [Related]
6. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
[No Abstract] [Full Text] [Related]
7. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
[TBL] [Abstract][Full Text] [Related]
8. Molecular analyses in hemophilia B families: identification of six new mutations in the factor IX gene.
Espinós C; Casaña P; Haya S; Cid AR; Aznar JA
Haematologica; 2003 Feb; 88(2):235-6. PubMed ID: 12604421
[No Abstract] [Full Text] [Related]
9. Heteroduplex analysis in hemophilia B: detection of two novel factor IX gene mutations.
Driscoll MC; Chu A; Hilgartner MW
Am J Hematol; 1996 Apr; 51(4):324-7. PubMed ID: 8602635
[TBL] [Abstract][Full Text] [Related]
10. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
[TBL] [Abstract][Full Text] [Related]
11. Mutations associated with hemophilia B in Turkish patients.
Cağlayan SH; Gökmen Y; Aktuğlu G; Gürgey A; Sommer SS
Hum Mutat; 1997; 10(1):76-9. PubMed ID: 9222764
[No Abstract] [Full Text] [Related]
12. Haemophilia B Leyden: the effect of mutations at position +13 on the liver-specific transcription of the factor IX gene.
Reijnen MJ; Maasdam D; Bertina RM; Reitsma PH
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):341-8. PubMed ID: 8075306
[TBL] [Abstract][Full Text] [Related]
13. [Mutational Analysis of Hemophilia B in Russia: Molecular-Genetic Study].
Surin VL; Demidova EY; Selivanova DS; Luchinina YA; Salomashkina VV; Pshenichnikova OS; Likhacheva EA
Genetika; 2016 Apr; 52(4):466-73. PubMed ID: 27529981
[TBL] [Abstract][Full Text] [Related]
14. Molecular genotyping of the Italian cohort of patients with hemophilia B.
Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
[TBL] [Abstract][Full Text] [Related]
15. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
[TBL] [Abstract][Full Text] [Related]
16. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
[TBL] [Abstract][Full Text] [Related]
17. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
[TBL] [Abstract][Full Text] [Related]
18. A new case of severe hemophilia B Leyden, associated with a G to C mutation at position -6 of the factor IX promoter.
Nguyen P; Cornillet P; Potron G
Am J Hematol; 1995 Jul; 49(3):259-60. PubMed ID: 7604825
[No Abstract] [Full Text] [Related]
19. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
Ludwig M; Sabharwal AK; Brackmann HH; Olek K; Smith KJ; Birktoft JJ; Bajaj SP
Blood; 1992 Mar; 79(5):1225-32. PubMed ID: 1346975
[TBL] [Abstract][Full Text] [Related]
20. The putative factor IX gene promoter in hemophilia B Leyden.
Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
